General Information
Revision date
2014-06-02
Product name
Atracurium Besylate Injection
Product Synonyms
2,2’–[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4- dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2- methylisoquinolinium] dibenzenesulfonate
CAS No.
64228-81-5
Manufacturer Name
Hospira, Inc
Icons in SDS
Company Information
company name
Hospira, Inc
GHS Information
Signal word
Warning
Section 2
SECTION 2: Hazards identification
GHS Classification Emergency Overview Atracurium Besylate Injection is a solution containing atracurium besylate, an intermediate-duration, nondepolarizing, skeletal muscle relaxant for intravenous administration. Clinically, it is used as an adjunct to general anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. In the workplace, atracurium besylate should be considered a potent drug and possibly irritating to the eyes and respiratory tract. Possible target organs include the neuromuscular system, cardiovascular system, and respiratory system. U.S. OSHA GHS Classification
Hazard categories
Not Classified STOT - RE 2
Signal word
Warning
Hazard statements
May cause damage to organs through prolonged or repeated exposure
Prevention
Do not breathe vapor or spray. Wash hands thoroughly after handling.
Response
Get medical attention if you feel unwell. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists, get medical attention. 1
